158 related articles for article (PubMed ID: 20614029)
1. Specific visualization of glioma cells in living low-grade tumor tissue.
Kantelhardt SR; Caarls W; de Vries AH; Hagen GM; Jovin TM; Schulz-Schaeffer W; Rohde V; Giese A; Arndt-Jovin DJ
PLoS One; 2010 Jun; 5(6):e11323. PubMed ID: 20614029
[TBL] [Abstract][Full Text] [Related]
2. DSE promotes aggressive glioma cell phenotypes by enhancing HB-EGF/ErbB signaling.
Liao WC; Liao CK; Tsai YH; Tseng TJ; Chuang LC; Lan CT; Chang HM; Liu CH
PLoS One; 2018; 13(6):e0198364. PubMed ID: 29864158
[TBL] [Abstract][Full Text] [Related]
3. Tumor-targeted quantum dots can help surgeons find tumor boundaries.
Arndt-Jovin DJ; Kantelhardt SR; Caarls W; de Vries AH; Giese A; Jovin Ast TM
IEEE Trans Nanobioscience; 2009 Mar; 8(1):65-71. PubMed ID: 19304503
[TBL] [Abstract][Full Text] [Related]
4. Study of the biodistribution of fluorescein in glioma-infiltrated mouse brain and histopathological correlation of intraoperative findings in high-grade gliomas resected under fluorescein fluorescence guidance.
Diaz RJ; Dios RR; Hattab EM; Burrell K; Rakopoulos P; Sabha N; Hawkins C; Zadeh G; Rutka JT; Cohen-Gadol AA
J Neurosurg; 2015 Jun; 122(6):1360-9. PubMed ID: 25839919
[TBL] [Abstract][Full Text] [Related]
5. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent Affibody Molecule Administered In Vivo at a Microdose Level Labels EGFR Expressing Glioma Tumor Regions.
de Souza AL; Marra K; Gunn J; Samkoe KS; Hoopes PJ; Feldwisch J; Paulsen KD; Pogue BW
Mol Imaging Biol; 2017 Feb; 19(1):41-48. PubMed ID: 27379987
[TBL] [Abstract][Full Text] [Related]
7. Introduction of a standardized multimodality image protocol for navigation-guided surgery of suspected low-grade gliomas.
Mert A; Kiesel B; Wöhrer A; Martínez-Moreno M; Minchev G; Furtner J; Knosp E; Wolfsberger S; Widhalm G
Neurosurg Focus; 2015 Jan; 38(1):E4. PubMed ID: 25552284
[TBL] [Abstract][Full Text] [Related]
8. Combined treatment of Nimotuzumab and rapamycin is effective against temozolomide-resistant human gliomas regardless of the EGFR mutation status.
Chong DQ; Toh XY; Ho IA; Sia KC; Newman JP; Yulyana Y; Ng WH; Lai SH; Ho MM; Dinesh N; Tham CK; Lam PY
BMC Cancer; 2015 Apr; 15():255. PubMed ID: 25886314
[TBL] [Abstract][Full Text] [Related]
9. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
10. Accuracy of High-Field Intraoperative MRI in the Detectability of Residual Tumor in Glioma Grade IV Resections.
Heßelmann V; Mager AK; Goetz C; Detsch O; Theisgen HK; Friese M; Schwindt W; Gottschalk J; Kremer P
Rofo; 2017 Jun; 189(6):519-526. PubMed ID: 28591887
[No Abstract] [Full Text] [Related]
11. Targeting ErbB receptors in high-grade glioma.
Berezowska S; Schlegel J
Curr Pharm Des; 2011; 17(23):2468-87. PubMed ID: 21827413
[TBL] [Abstract][Full Text] [Related]
12. Targeted signal-amplifying enzymes enhance MRI of EGFR expression in an orthotopic model of human glioma.
Shazeeb MS; Sotak CH; DeLeo M; Bogdanov A
Cancer Res; 2011 Mar; 71(6):2230-9. PubMed ID: 21245103
[TBL] [Abstract][Full Text] [Related]
13. Epidermal growth factor receptor and glioblastoma multiforme: molecular basis for a new approach.
Belda-Iniesta C; de Castro Carpeño J; Sereno M; González-Barón M; Perona R
Clin Transl Oncol; 2008 Feb; 10(2):73-7. PubMed ID: 18258505
[TBL] [Abstract][Full Text] [Related]
14. MRI-coupled fluorescence tomography quantifies EGFR activity in brain tumors.
Davis SC; Samkoe KS; O'Hara JA; Gibbs-Strauss SL; Payne HL; Hoopes PJ; Paulsen KD; Pogue BW
Acad Radiol; 2010 Mar; 17(3):271-6. PubMed ID: 20152724
[TBL] [Abstract][Full Text] [Related]
15. Finding the anaplastic focus in diffuse gliomas: the value of Gd-DTPA enhanced MRI, FET-PET, and intraoperative, ALA-derived tissue fluorescence.
Ewelt C; Floeth FW; Felsberg J; Steiger HJ; Sabel M; Langen KJ; Stoffels G; Stummer W
Clin Neurol Neurosurg; 2011 Sep; 113(7):541-7. PubMed ID: 21507562
[TBL] [Abstract][Full Text] [Related]
16. [Intraoperative use of an open mid-field MR scanner in the surgical treatment of cerebral gliomas].
Schneider JP; Trantakis C; Schulz T; Dietrich J; Kahn T
Z Med Phys; 2003; 13(3):214-8. PubMed ID: 14562547
[TBL] [Abstract][Full Text] [Related]
17. Motility of glioblastoma cells is driven by netrin-1 induced gain of stemness.
Ylivinkka I; Sihto H; Tynninen O; Hu Y; Laakso A; Kivisaari R; Laakkonen P; Keski-Oja J; Hyytiäinen M
J Exp Clin Cancer Res; 2017 Jan; 36(1):9. PubMed ID: 28069038
[TBL] [Abstract][Full Text] [Related]
18. Threshold of the extent of resection for WHO Grade III gliomas: retrospective volumetric analysis of 122 cases using intraoperative MRI.
Fujii Y; Muragaki Y; Maruyama T; Nitta M; Saito T; Ikuta S; Iseki H; Hongo K; Kawamata T
J Neurosurg; 2018 Jul; 129(1):1-9. PubMed ID: 28885120
[TBL] [Abstract][Full Text] [Related]
19. Aptamer-conjugated PEGylated quantum dots targeting epidermal growth factor receptor variant III for fluorescence imaging of glioma.
Tang J; Huang N; Zhang X; Zhou T; Tan Y; Pi J; Pi L; Cheng S; Zheng H; Cheng Y
Int J Nanomedicine; 2017; 12():3899-3911. PubMed ID: 28579776
[TBL] [Abstract][Full Text] [Related]
20. EGFR immunolabeling pattern may discriminate low-grade gliomas from gliosis.
Burel-Vandenbos F; Benchetrit M; Miquel C; Fontaine D; Auvergne R; Lebrun-Frenay C; Cardot-Leccia N; Michiels JF; Paquis-Flucklinger V; Virolle T
J Neurooncol; 2011 Apr; 102(2):171-8. PubMed ID: 20652725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]